Cullinan Therapeutics, Inc. · NASDAQ:CGEM

The Vanguard Group reported a 5.58% stake in Cullinan Therapeutics, Inc. (Schedule 13G)

Event Dec 31, 2025 · Filed Jan 30, 2026

The Vanguard Group reported a 5.58% stake in Cullinan Therapeutics, Inc., 3,298,504 shares, as a passive investor on Dec 31, 2025. Filed Jan 30, 2026 (Schedule 13G).

Stake
5.58%
Shares
3,298,504
Intent
Passive
What changed
Crossed above 5%

The filing in full

HolderStakeShares
The Vanguard Group5.58%3,298,504

Source

View original at SEC

Related